Birchview Capital »

Miragen Therapeutics shares owned by Birchview Capital

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Birchview Capital from 13F filings

Historical chart of Birchview Capital investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Birchview Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Birchview Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $393k 20k 19.56